Header Logo

Phase I trial of donor-derived modified immune cell infusion in kidney transplantation.

Phase I trial of donor-derived modified immune cell infusion in kidney transplantation. J Clin Invest. 2020 05 01; 130(5):2364-2376.

View in: PubMed